1. Home
  2. NEWS
  3. Viron's CEO unveils Viron C1, an anti-COVID-19 nasal spray

Viron's CEO unveils Viron C1, an anti-COVID-19 nasal spray

Viron's CEO unveils Viron C1, an anti-COVID-19 nasal spray

December 17, 2021

Porosome Therapeutics Announces its Patent Estate Review Results: “The strategic analysis confirmed that Porosome Therapeutics occupies a distinct and defensibleintellectual property position within the emerging field of secretion restoration technologies. Porosome Therapeutics has successfully carved out a highly defensible white space” (March 11, 2026)
From the Chairman's Desk (Feb. 23, 2026) Porosome Therapeutics Therapies
From the CEO's DESK (2026)